img

Global Peroxisome Proliferator Activated Receptor Delta Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Peroxisome Proliferator Activated Receptor Delta Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Peroxisome Proliferator Activated Receptor Delta report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Peroxisome Proliferator Activated Receptor Delta market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Bone Disorders and Colitis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Peroxisome Proliferator Activated Receptor Delta industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Peroxisome Proliferator Activated Receptor Delta key manufacturers include Chipscreen Biosciences Ltd, Connexios Life Sciences Pvt Ltd, CymaBay Therapeutics Inc, Genfit SA, Inventiva, Mitobridge Inc, Nippon Chemiphar Co Ltd, Senju Pharmaceutical Co Ltd and T3D Therapeutics Inc, etc. Chipscreen Biosciences Ltd, Connexios Life Sciences Pvt Ltd, CymaBay Therapeutics Inc are top 3 players and held % sales share in total in 2022.
Peroxisome Proliferator Activated Receptor Delta can be divided into MTB-2, HPP-593, CNX-013B2 and CS-038, etc. MTB-2 is the mainstream product in the market, accounting for % sales share globally in 2022.
Peroxisome Proliferator Activated Receptor Delta is widely used in various fields, such as Bone Disorders, Colitis, Obesity and Osteoporosis, etc. Bone Disorders provides greatest supports to the Peroxisome Proliferator Activated Receptor Delta industry development. In 2022, global % sales of Peroxisome Proliferator Activated Receptor Delta went into Bone Disorders filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Peroxisome Proliferator Activated Receptor Delta market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Chipscreen Biosciences Ltd
Connexios Life Sciences Pvt Ltd
CymaBay Therapeutics Inc
Genfit SA
Inventiva
Mitobridge Inc
Nippon Chemiphar Co Ltd
Senju Pharmaceutical Co Ltd
T3D Therapeutics Inc
Segment by Type
MTB-2
HPP-593
CNX-013B2
CS-038
MA-0204
Others

Segment by Application


Bone Disorders
Colitis
Obesity
Osteoporosis
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Peroxisome Proliferator Activated Receptor Delta market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Peroxisome Proliferator Activated Receptor Delta, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Peroxisome Proliferator Activated Receptor Delta industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Peroxisome Proliferator Activated Receptor Delta in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Peroxisome Proliferator Activated Receptor Delta introduction, etc. Peroxisome Proliferator Activated Receptor Delta Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Peroxisome Proliferator Activated Receptor Delta market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Peroxisome Proliferator Activated Receptor Delta Market Overview
1.1 Peroxisome Proliferator Activated Receptor Delta Product Overview
1.2 Peroxisome Proliferator Activated Receptor Delta Market Segment by Type
1.2.1 MTB-2
1.2.2 HPP-593
1.2.3 CNX-013B2
1.2.4 CS-038
1.2.5 MA-0204
1.2.6 Others
1.3 Global Peroxisome Proliferator Activated Receptor Delta Market Size by Type
1.3.1 Global Peroxisome Proliferator Activated Receptor Delta Market Size Overview by Type (2018-2034)
1.3.2 Global Peroxisome Proliferator Activated Receptor Delta Historic Market Size Review by Type (2018-2024)
1.3.3 Global Peroxisome Proliferator Activated Receptor Delta Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Peroxisome Proliferator Activated Receptor Delta Sales Breakdown by Type (2018-2024)
1.4.2 Europe Peroxisome Proliferator Activated Receptor Delta Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Peroxisome Proliferator Activated Receptor Delta Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales Breakdown by Type (2018-2024)
2 Global Peroxisome Proliferator Activated Receptor Delta Market Competition by Company
2.1 Global Top Players by Peroxisome Proliferator Activated Receptor Delta Sales (2018-2024)
2.2 Global Top Players by Peroxisome Proliferator Activated Receptor Delta Revenue (2018-2024)
2.3 Global Top Players by Peroxisome Proliferator Activated Receptor Delta Price (2018-2024)
2.4 Global Top Manufacturers Peroxisome Proliferator Activated Receptor Delta Manufacturing Base Distribution, Sales Area, Product Type
2.5 Peroxisome Proliferator Activated Receptor Delta Market Competitive Situation and Trends
2.5.1 Peroxisome Proliferator Activated Receptor Delta Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Peroxisome Proliferator Activated Receptor Delta Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peroxisome Proliferator Activated Receptor Delta as of 2022)
2.7 Date of Key Manufacturers Enter into Peroxisome Proliferator Activated Receptor Delta Market
2.8 Key Manufacturers Peroxisome Proliferator Activated Receptor Delta Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Peroxisome Proliferator Activated Receptor Delta Status and Outlook by Region
3.1 Global Peroxisome Proliferator Activated Receptor Delta Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Peroxisome Proliferator Activated Receptor Delta Historic Market Size by Region
3.2.1 Global Peroxisome Proliferator Activated Receptor Delta Sales in Volume by Region (2018-2024)
3.2.2 Global Peroxisome Proliferator Activated Receptor Delta Sales in Value by Region (2018-2024)
3.2.3 Global Peroxisome Proliferator Activated Receptor Delta Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Peroxisome Proliferator Activated Receptor Delta Forecasted Market Size by Region
3.3.1 Global Peroxisome Proliferator Activated Receptor Delta Sales in Volume by Region (2024-2034)
3.3.2 Global Peroxisome Proliferator Activated Receptor Delta Sales in Value by Region (2024-2034)
3.3.3 Global Peroxisome Proliferator Activated Receptor Delta Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Peroxisome Proliferator Activated Receptor Delta by Application
4.1 Peroxisome Proliferator Activated Receptor Delta Market Segment by Application
4.1.1 Bone Disorders
4.1.2 Colitis
4.1.3 Obesity
4.1.4 Osteoporosis
4.1.5 Others
4.2 Global Peroxisome Proliferator Activated Receptor Delta Market Size by Application
4.2.1 Global Peroxisome Proliferator Activated Receptor Delta Market Size Overview by Application (2018-2034)
4.2.2 Global Peroxisome Proliferator Activated Receptor Delta Historic Market Size Review by Application (2018-2024)
4.2.3 Global Peroxisome Proliferator Activated Receptor Delta Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Peroxisome Proliferator Activated Receptor Delta Sales Breakdown by Application (2018-2024)
4.3.2 Europe Peroxisome Proliferator Activated Receptor Delta Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Peroxisome Proliferator Activated Receptor Delta Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales Breakdown by Application (2018-2024)
5 North America Peroxisome Proliferator Activated Receptor Delta by Country
5.1 North America Peroxisome Proliferator Activated Receptor Delta Historic Market Size by Country
5.1.1 North America Peroxisome Proliferator Activated Receptor Delta Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Peroxisome Proliferator Activated Receptor Delta Sales in Volume by Country (2018-2024)
5.1.3 North America Peroxisome Proliferator Activated Receptor Delta Sales in Value by Country (2018-2024)
5.2 North America Peroxisome Proliferator Activated Receptor Delta Forecasted Market Size by Country
5.2.1 North America Peroxisome Proliferator Activated Receptor Delta Sales in Volume by Country (2024-2034)
5.2.2 North America Peroxisome Proliferator Activated Receptor Delta Sales in Value by Country (2024-2034)
6 Europe Peroxisome Proliferator Activated Receptor Delta by Country
6.1 Europe Peroxisome Proliferator Activated Receptor Delta Historic Market Size by Country
6.1.1 Europe Peroxisome Proliferator Activated Receptor Delta Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Peroxisome Proliferator Activated Receptor Delta Sales in Volume by Country (2018-2024)
6.1.3 Europe Peroxisome Proliferator Activated Receptor Delta Sales in Value by Country (2018-2024)
6.2 Europe Peroxisome Proliferator Activated Receptor Delta Forecasted Market Size by Country
6.2.1 Europe Peroxisome Proliferator Activated Receptor Delta Sales in Volume by Country (2024-2034)
6.2.2 Europe Peroxisome Proliferator Activated Receptor Delta Sales in Value by Country (2024-2034)
7 Asia-Pacific Peroxisome Proliferator Activated Receptor Delta by Region
7.1 Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Historic Market Size by Region
7.1.1 Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Forecasted Market Size by Region
7.2.1 Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales in Value by Region (2024-2034)
8 Latin America Peroxisome Proliferator Activated Receptor Delta by Country
8.1 Latin America Peroxisome Proliferator Activated Receptor Delta Historic Market Size by Country
8.1.1 Latin America Peroxisome Proliferator Activated Receptor Delta Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Peroxisome Proliferator Activated Receptor Delta Sales in Volume by Country (2018-2024)
8.1.3 Latin America Peroxisome Proliferator Activated Receptor Delta Sales in Value by Country (2018-2024)
8.2 Latin America Peroxisome Proliferator Activated Receptor Delta Forecasted Market Size by Country
8.2.1 Latin America Peroxisome Proliferator Activated Receptor Delta Sales in Volume by Country (2024-2034)
8.2.2 Latin America Peroxisome Proliferator Activated Receptor Delta Sales in Value by Country (2024-2034)
9 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta by Country
9.1 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Historic Market Size by Country
9.1.1 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Forecasted Market Size by Country
9.2.1 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Chipscreen Biosciences Ltd
10.1.1 Chipscreen Biosciences Ltd Company Information
10.1.2 Chipscreen Biosciences Ltd Introduction and Business Overview
10.1.3 Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Products Offered
10.1.5 Chipscreen Biosciences Ltd Recent Development
10.2 Connexios Life Sciences Pvt Ltd
10.2.1 Connexios Life Sciences Pvt Ltd Company Information
10.2.2 Connexios Life Sciences Pvt Ltd Introduction and Business Overview
10.2.3 Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Products Offered
10.2.5 Connexios Life Sciences Pvt Ltd Recent Development
10.3 CymaBay Therapeutics Inc
10.3.1 CymaBay Therapeutics Inc Company Information
10.3.2 CymaBay Therapeutics Inc Introduction and Business Overview
10.3.3 CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2018-2024)
10.3.4 CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Products Offered
10.3.5 CymaBay Therapeutics Inc Recent Development
10.4 Genfit SA
10.4.1 Genfit SA Company Information
10.4.2 Genfit SA Introduction and Business Overview
10.4.3 Genfit SA Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Genfit SA Peroxisome Proliferator Activated Receptor Delta Products Offered
10.4.5 Genfit SA Recent Development
10.5 Inventiva
10.5.1 Inventiva Company Information
10.5.2 Inventiva Introduction and Business Overview
10.5.3 Inventiva Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Inventiva Peroxisome Proliferator Activated Receptor Delta Products Offered
10.5.5 Inventiva Recent Development
10.6 Mitobridge Inc
10.6.1 Mitobridge Inc Company Information
10.6.2 Mitobridge Inc Introduction and Business Overview
10.6.3 Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Products Offered
10.6.5 Mitobridge Inc Recent Development
10.7 Nippon Chemiphar Co Ltd
10.7.1 Nippon Chemiphar Co Ltd Company Information
10.7.2 Nippon Chemiphar Co Ltd Introduction and Business Overview
10.7.3 Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Products Offered
10.7.5 Nippon Chemiphar Co Ltd Recent Development
10.8 Senju Pharmaceutical Co Ltd
10.8.1 Senju Pharmaceutical Co Ltd Company Information
10.8.2 Senju Pharmaceutical Co Ltd Introduction and Business Overview
10.8.3 Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Products Offered
10.8.5 Senju Pharmaceutical Co Ltd Recent Development
10.9 T3D Therapeutics Inc
10.9.1 T3D Therapeutics Inc Company Information
10.9.2 T3D Therapeutics Inc Introduction and Business Overview
10.9.3 T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2018-2024)
10.9.4 T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Products Offered
10.9.5 T3D Therapeutics Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Peroxisome Proliferator Activated Receptor Delta Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Peroxisome Proliferator Activated Receptor Delta Industrial Chain Analysis
11.4 Peroxisome Proliferator Activated Receptor Delta Market Dynamics
11.4.1 Peroxisome Proliferator Activated Receptor Delta Industry Trends
11.4.2 Peroxisome Proliferator Activated Receptor Delta Market Drivers
11.4.3 Peroxisome Proliferator Activated Receptor Delta Market Challenges
11.4.4 Peroxisome Proliferator Activated Receptor Delta Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Peroxisome Proliferator Activated Receptor Delta Distributors
12.3 Peroxisome Proliferator Activated Receptor Delta Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of MTB-2
Table 2. Major Company of HPP-593
Table 3. Major Company of CNX-013B2
Table 4. Major Company of CS-038
Table 5. Major Company of MA-0204
Table 6. Major Company of Others
Table 7. Global Peroxisome Proliferator Activated Receptor Delta Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Peroxisome Proliferator Activated Receptor Delta Sales by Type (2018-2024) & (K Pcs)
Table 9. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Type (2018-2024)
Table 10. Global Peroxisome Proliferator Activated Receptor Delta Sales by Type (2018-2024) & (US& Million)
Table 11. Global Peroxisome Proliferator Activated Receptor Delta Market Share in Value by Type (2018-2024)
Table 12. Global Peroxisome Proliferator Activated Receptor Delta Price by Type (2018-2024) & (USD/Pcs)
Table 13. Global Peroxisome Proliferator Activated Receptor Delta Sales by Type (2024-2034) & (K Pcs)
Table 14. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Type (2024-2034)
Table 15. Global Peroxisome Proliferator Activated Receptor Delta Sales by Type (2024-2034) & (US$ Million)
Table 16. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Type (2024-2034)
Table 17. Global Peroxisome Proliferator Activated Receptor Delta Price by Type (2024-2034) & (USD/Pcs)
Table 18. North America Peroxisome Proliferator Activated Receptor Delta Sales by Type (2018-2024) & (K Pcs)
Table 19. North America Peroxisome Proliferator Activated Receptor Delta Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Type (2018-2024)
Table 21. Europe Peroxisome Proliferator Activated Receptor Delta Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Type (2018-2024)
Table 23. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Type (2018-2024)
Table 25. Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Type (2018-2024)
Table 27. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Type (2018-2024) & (US$ Million)
Table 28. Global Peroxisome Proliferator Activated Receptor Delta Sales by Company (2018-2024) & (K Pcs)
Table 29. Global Peroxisome Proliferator Activated Receptor Delta Sales Share by Company (2018-2024)
Table 30. Global Peroxisome Proliferator Activated Receptor Delta Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global Peroxisome Proliferator Activated Receptor Delta Revenue Share by Company (2018-2024)
Table 32. Global Market Peroxisome Proliferator Activated Receptor Delta Price by Company (2018-2024) & (USD/Pcs)
Table 33. Global Peroxisome Proliferator Activated Receptor Delta Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Peroxisome Proliferator Activated Receptor Delta Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peroxisome Proliferator Activated Receptor Delta as of 2022)
Table 36. Date of Key Manufacturers Enter into Peroxisome Proliferator Activated Receptor Delta Market
Table 37. Key Manufacturers Peroxisome Proliferator Activated Receptor Delta Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Peroxisome Proliferator Activated Receptor Delta Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Global Peroxisome Proliferator Activated Receptor Delta Sales by Region (2018-2024) & (K Pcs)
Table 41. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Region (2018-2024)
Table 42. Global Peroxisome Proliferator Activated Receptor Delta Sales by Region (2018-2024) & (US$ Million)
Table 43. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Region (2018-2024)
Table 44. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 45. Global Peroxisome Proliferator Activated Receptor Delta Sales by Region (2024-2034) & (K Pcs)
Table 46. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Region (2024-2034)
Table 47. Global Peroxisome Proliferator Activated Receptor Delta Sales by Region (2024-2034) & (US$ Million)
Table 48. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Region (2024-2034)
Table 49. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 50. Global Peroxisome Proliferator Activated Receptor Delta Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 51. Global Peroxisome Proliferator Activated Receptor Delta Sales by Application (2018-2024) & (K Pcs)
Table 52. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Application (2018-2024)
Table 53. Global Peroxisome Proliferator Activated Receptor Delta Sales by Application (2018-2024) & (US$ Million)
Table 54. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Application (2018-2024)
Table 55. Global Peroxisome Proliferator Activated Receptor Delta Price by Application (2018-2024) & (USD/Pcs)
Table 56. Global Peroxisome Proliferator Activated Receptor Delta Sales by Application (2024-2034) & (K Pcs)
Table 57. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Application (2024-2034)
Table 58. Global Peroxisome Proliferator Activated Receptor Delta Sales by Application (2024-2034) & (US$ Million)
Table 59. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Application (2024-2034)
Table 60. Global Peroxisome Proliferator Activated Receptor Delta Price by Application (2024-2034) & (USD/Pcs)
Table 61. North America Peroxisome Proliferator Activated Receptor Delta Sales by Application (2018-2024) (K Pcs)
Table 62. North America Peroxisome Proliferator Activated Receptor Delta Sales by Application (2018-2024) & (US$ Million)
Table 63. Europe Peroxisome Proliferator Activated Receptor Delta Sales by Application (2018-2024) (K Pcs)
Table 64. Europe Peroxisome Proliferator Activated Receptor Delta Sales by Application (2018-2024) & (US$ Million)
Table 65. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Application (2018-2024) (K Pcs)
Table 66. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Application (2018-2024) & (US$ Million)
Table 67. Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Application (2018-2024) (K Pcs)
Table 68. Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Application (2018-2024) & (US$ Million)
Table 69. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Application (2018-2024) (K Pcs)
Table 70. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Application (2018-2024) & (US$ Million)
Table 71. North America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2018-2024) & (K Pcs)
Table 72. North America Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Country (2018-2024)
Table 73. North America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2018-2024) & (US$ Million)
Table 74. North America Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Country (2018-2024)
Table 75. North America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2024-2034) & (K Pcs)
Table 76. North America Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Country (2024-2034)
Table 77. North America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2024-2034) & (US$ Million)
Table 78. North America Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Country (2024-2034)
Table 79. Europe Peroxisome Proliferator Activated Receptor Delta Sales by Country (2018-2024) & (K Pcs)
Table 80. Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe Peroxisome Proliferator Activated Receptor Delta Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Country (2018-2024)
Table 83. Europe Peroxisome Proliferator Activated Receptor Delta Sales by Country (2024-2034) & (K Pcs)
Table 84. Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe Peroxisome Proliferator Activated Receptor Delta Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Region (2018-2024) & (K Pcs)
Table 88. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Region (2024-2034) & (K Pcs)
Table 92. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2018-2024) & (K Pcs)
Table 96. Latin America Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2024-2034) & (K Pcs)
Table 100. Latin America Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Country (2018-2024) & (K Pcs)
Table 104. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Country (2024-2034) & (K Pcs)
Table 108. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Country (2024-2034)
Table 111. Chipscreen Biosciences Ltd Company Information
Table 112. Chipscreen Biosciences Ltd Introduction and Business Overview
Table 113. Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 114. Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Product
Table 115. Chipscreen Biosciences Ltd Recent Development
Table 116. Connexios Life Sciences Pvt Ltd Company Information
Table 117. Connexios Life Sciences Pvt Ltd Introduction and Business Overview
Table 118. Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 119. Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Product
Table 120. Connexios Life Sciences Pvt Ltd Recent Development
Table 121. CymaBay Therapeutics Inc Company Information
Table 122. CymaBay Therapeutics Inc Introduction and Business Overview
Table 123. CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 124. CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Product
Table 125. CymaBay Therapeutics Inc Recent Development
Table 126. Genfit SA Company Information
Table 127. Genfit SA Introduction and Business Overview
Table 128. Genfit SA Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 129. Genfit SA Peroxisome Proliferator Activated Receptor Delta Product
Table 130. Genfit SA Recent Development
Table 131. Inventiva Company Information
Table 132. Inventiva Introduction and Business Overview
Table 133. Inventiva Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 134. Inventiva Peroxisome Proliferator Activated Receptor Delta Product
Table 135. Inventiva Recent Development
Table 136. Mitobridge Inc Company Information
Table 137. Mitobridge Inc Introduction and Business Overview
Table 138. Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 139. Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Product
Table 140. Mitobridge Inc Recent Development
Table 141. Nippon Chemiphar Co Ltd Company Information
Table 142. Nippon Chemiphar Co Ltd Introduction and Business Overview
Table 143. Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 144. Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Product
Table 145. Nippon Chemiphar Co Ltd Recent Development
Table 146. Senju Pharmaceutical Co Ltd Company Information
Table 147. Senju Pharmaceutical Co Ltd Introduction and Business Overview
Table 148. Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 149. Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Product
Table 150. Senju Pharmaceutical Co Ltd Recent Development
Table 151. T3D Therapeutics Inc Company Information
Table 152. T3D Therapeutics Inc Introduction and Business Overview
Table 153. T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 154. T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Product
Table 155. T3D Therapeutics Inc Recent Development
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Peroxisome Proliferator Activated Receptor Delta Market Trends
Table 159. Peroxisome Proliferator Activated Receptor Delta Market Drivers
Table 160. Peroxisome Proliferator Activated Receptor Delta Market Challenges
Table 161. Peroxisome Proliferator Activated Receptor Delta Market Restraints
Table 162. Peroxisome Proliferator Activated Receptor Delta Distributors List
Table 163. Peroxisome Proliferator Activated Receptor Delta Downstream Customers
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Peroxisome Proliferator Activated Receptor Delta Product Picture
Figure 2. Global Peroxisome Proliferator Activated Receptor Delta Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Peroxisome Proliferator Activated Receptor Delta Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Peroxisome Proliferator Activated Receptor Delta Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of MTB-2
Figure 6. Global MTB-2 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of HPP-593
Figure 8. Global HPP-593 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of CNX-013B2
Figure 10. Global CNX-013B2 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of CS-038
Figure 12. Global CS-038 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of MA-0204
Figure 14. Global MA-0204 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Product Picture of Others
Figure 16. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 17. Global Peroxisome Proliferator Activated Receptor Delta Sales by Type (2018-2034) & (US$ Million)
Figure 18. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type in 2022 & 2034
Figure 19. North America Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Type in 2022
Figure 20. North America Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Type in 2022
Figure 21. Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Type in 2022
Figure 22. Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Type in 2022
Figure 25. Latin America Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Type in 2022
Figure 26. Latin America Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Peroxisome Proliferator Activated Receptor Delta Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Peroxisome Proliferator Activated Receptor Delta Revenue in 2022
Figure 31. Peroxisome Proliferator Activated Receptor Delta Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of Bone Disorders
Figure 33. Global Bone Disorders Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Colitis
Figure 35. Global Colitis Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Obesity
Figure 37. Global Obesity Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Product Picture of Osteoporosis
Figure 39. Global Osteoporosis Sales YoY Growth (2018-2034) & (K Pcs)
Figure 40. Product Picture of Others
Figure 41. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 42. Global Peroxisome Proliferator Activated Receptor Delta Sales by Application (2018-2034) & (US$ Million)
Figure 43. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application in 2022 & 2034
Figure 44. North America Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Application in 2022
Figure 45. North America Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Application in 2022
Figure 46. Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Application in 2022
Figure 47. Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Application in 2022
Figure 48. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Application in 2022
Figure 49. Asia-Pacific Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Application in 2022
Figure 50. Latin America Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Volume by Application in 2022
Figure 51. Latin America Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Application in 2022
Figure 52. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales Market Share in Value by Application in 2022
Figure 53. Key Raw Materials Price
Figure 54. Peroxisome Proliferator Activated Receptor Delta Manufacturing Cost Structure
Figure 55. Peroxisome Proliferator Activated Receptor Delta Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries